スマートステントの世界市場：2025年～2033年

世界のスマートステントの市場規模は、2024年に23億米ドルに達し、2033年には40億1,000万米ドルに達すると予測され、予測期間の2025年～2033年のCAGRは5.7%になると見込まれています。

スマートステントは、体内の血管やその他の管状構造の閉塞や狭窄を治療するために設計された先進医療機器です。従来のステントは単に血管を開くための構造的支持を提供するものでしたが、スマートステントはリアルタイムモニタリングと機能強化を可能にする統合センサーと技術を備えています。これらのセンサーは、血流、圧力、温度、組織の酸素レベルなど様々な生理学的パラメータを追跡することができ、処置中や処置後にヘルスケア専門家に貴重なデータを提供します。

低侵襲手技に対する需要の高まりは、ヘルスケアプロバイダーと患者の双方にとってこれらの先進デバイスをより望ましいものにすることで、スマートステント市場を牽引すると予想されます。より小さな切開、回復時間の短縮、術後の痛みの軽減などの利点を提供する低侵襲処置は、心血管疾患、腎臓障害、その他の血管問題などの症状を治療するための好ましい選択肢になりつつあります。例えば、Cleveland Clinicの調査によると、米国の医療従事者は毎年約60万件の冠動脈ステント治療を行っています。

リアルタイムのモニタリング、ドラッグデリバリー、手術中の精度向上のためのセンサーを統合したスマートステントは、低侵襲治療への傾向の高まりと完全に合致しています。これらのステントにより、外科医は動脈や血管の状態をモニターし、合併症のリスクを低減し、患者の予後を改善することができます。外傷や回復に要する時間を最小限に抑える手術に対する需要が高まり続ける中、スマートステントは市場を牽引する重要な役割を果たすと考えられています。

スマートセンサーのコストが高いため、その利用が制限され、スマートステント市場の妨げになると予想されます。スマートステントには、リアルタイムのモニタリングとデータ送信を可能にする高度なセンサー技術が組み込まれていますが、こうしたセンサーの開発と製造にはコストがかかります。製造コストの増加はヘルスケアプロバイダーや患者に転嫁されることが多く、スマートステントは従来のステントよりもかなり高価になっています。このため、特にヘルスケア予算が限られている新興諸国では、採用率が低下する可能性があります。

当レポートでは、世界のスマートステント市場について調査し、市場の概要とともに、タイプ別、エンドユーザー別、地域別動向、競合情勢、および市場に参入する企業のプロファイルなどを提供しています。

目次

第1章 調査手法と範囲

第2章 定義と概要

第3章 エグゼクティブサマリー

第4章 市場力学

• 影響要因
  • 促進要因
  • 抑制要因
  • 機会
  • 影響分析

第5章 戦略的洞察と業界展望

• 市場のリーダーと先駆者
• CXOの視点
• 最新の開発とブレークスルー
• ケーススタディ/進行中の調査
• 規制と償還の情勢
• ポーターのファイブフォース分析
• サプライチェーン分析
• 特許分析
• SWOT分析
• アンメットニーズとギャップ
• 市場参入と拡大のための推奨戦略
• シナリオ分析ベストケース、ベースケース、ワーストケースの予測
• 価格分析と価格動向
• キーオピニオンリーダー

第6章 タイプ別

• 心臓血管用スマートステント
• 泌尿器科用スマートステント
• 胆管用スマートステント
• 呼吸器用スマートステント
• その他

第7章 エンドユーザー別

• 病院
• 外来手術センター（ASC）
• 専門クリニック

第8章 地域別

• 北米
  • 米国
  • カナダ
• 欧州
  • ドイツ
  • 英国
  • フランス
  • スペイン
  • イタリア
  • その他
• ラテンアメリカ
  • メキシコ
  • ブラジル
  • アルゼンチン
  • その他
• アジア太平洋
  • 中国
  • インド
  • 日本
  • 韓国
  • その他
• 中東・アフリカ

第9章 競合情勢

第10章 企業プロファイル

• Cordis
• Boston Scientific Corporation
• Abbott
• Medtronic
• Balton
• Biotronik

第11章 付録

The global smart stents market reached US$ 2.3 billion in 2024 and is expected to reach US$ 4.01 billion by 2033, growing at a CAGR of 5.7% during the forecast period 2025-2033.

Smart stents are advanced medical devices designed to treat blockages or narrowing in blood vessels or other tubular structures in the body. Unlike traditional stents, which simply provide structural support to keep blood vessels open, smart stents are equipped with integrated sensors and technology that enable real-time monitoring and enhanced functionality. These sensors can track various physiological parameters such as blood flow, pressure, temperature, or tissue oxygen levels, providing valuable data to healthcare professionals during and after procedures.

Market Dynamics: Drivers & Restraints

Increasing Demand for Minimally Invasive Procedures

The increasing demand for minimally invasive procedures is expected to drive the smart stents market by making these advanced devices more desirable for both healthcare providers and patients. Minimally invasive procedures, which offer benefits such as smaller incisions, reduced recovery times, and less post-operative pain, are becoming the preferred option for treating conditions like cardiovascular disease, kidney disorders, and other vascular issues. For instance, according to the Cleveland Clinic study, each year, healthcare providers in the United States perform about 600,000 coronary stent procedures.

Smart stents, which integrate sensors for real-time monitoring, drug delivery, and enhanced precision during surgery, align perfectly with the growing trend toward minimally invasive treatments. These stents enable surgeons to monitor the condition of the artery or vessel, reduce the risk of complications, and improve patient outcomes, all while minimizing the need for larger, more invasive surgeries. As the demand for procedures that minimize trauma and recovery time continues to grow, smart stents are positioned to play a key role in driving the market.

High Costs of Smart Stents

The high costs of smart sensors are expected to hinder the smart stents market by limiting their accessibility. Smart stents incorporate advanced sensor technologies that enable real-time monitoring and data transmission, but these sensors are expensive to develop and manufacture. The increased production costs are often passed on to healthcare providers and patients, making smart stents significantly more expensive than traditional stents. This can lead to a slower adoption rate, particularly in developing countries where healthcare budgets are limited.

Segment Analysis

The global smart stents market is segmented based on the type, end-user and region.

Cardiovascular smart stents in the type segment is expected to dominate the smart stents market

Cardiovascular smart stents are expected to dominate the smart stents market due to the high prevalence of cardiovascular diseases (CVDs) and the increasing adoption of minimally invasive procedures. Cardiovascular diseases, including coronary artery disease and heart attacks, are among the leading causes of death globally, creating a substantial need for effective treatment options. Smart stents in this segment offer enhanced benefits such as real-time monitoring of blood flow, pressure, and vessel conditions, as well as drug delivery systems that can reduce the risk of restenosis (re-narrowing of the arteries). These advanced features provide more precise treatment, better patient outcomes, and faster recovery times, making them highly sought after in the cardiovascular space.

Additionally, with significant advancements in technology and increasing demand for minimally invasive surgeries, cardiovascular smart stents offer a compelling solution for both patients and healthcare providers. For instance, in May 2024, Abbott launched the XIENCE Sierra Everolimus Eluting Coronary Stent System in India, further solidifying its dominance in the cardiovascular smart stents segment. As part of the renowned XIENCE family, the XIENCE Sierra is one of the latest-generation stents designed to treat patients with blocked coronary arteries. This advanced stent system offers unparalleled safety and precision, making it especially effective for the most complex cases encountered by interventional cardiologists. The launch of this next-generation smart stent underscores the continued growth and innovation within the cardiovascular sector.

This combination of high demand for effective cardiovascular treatments and the benefits of advanced smart stent technologies is driving their dominance in the market.

Geographical Analysis

North America is expected to dominate the smart stents market

North America is expected to dominate the smart stents market due to high demand for minimally invasive procedures, and great ability in medical device innovation. The region's healthcare system is quick to adopt cutting-edge technologies, including smart stents, which align with the growing trend toward less invasive surgeries that offer faster recovery and better outcomes.

Leading market players in the region are driving innovation and development in this market. Additionally, North America's region gaining strong regulatory approvals, strong research and development investments and aging population with increasing chronic diseases create a significant demand for smart stents. For instance, in March 2022, Cordis received approval for the S.M.A.R.T. RADIANZ Vascular Stent System by the U.S. Food and Drug Administration (FDA). This self-expanding stent is specifically engineered for radial peripheral procedures, allowing for precise and efficient placement in the iliac and superficial femoral arteries (SFA). The approval of this innovative stent system enhances the existing RADIANZ(TM) Radial Peripheral System, which also includes the BRITE TIP RADIANZ(TM) Guiding Sheath and SABERX RADIANZ PTA Catheter. This comprehensive system is designed to optimize radial access, improve procedural outcomes, and provide high levels of patient satisfaction.

The launch of such cutting-edge technologies further strengthens the growing role of smart stents in minimally invasive treatments, marking a major step forward in the smart stents market. These factors are expected to combinedly drive the region's growth.

Competitive Landscape

The global market players in the smart stents market are Cordis, Boston Scientific Corporation, Abbott, Medtronic, Balton, and Biotronik., among others.

Why Purchase the Report?

• Technological Innovations: Reviews ongoing clinical trials, and product pipelines, and forecasts upcoming pharmaceutical advancements.
• Type Performance & Market Positioning: Analyzes product performance, market positioning, and growth potential to optimize strategies.
• Real-World Evidence: Integrates patient feedback and data into product development for improved outcomes.
• Physician Preferences & Health System Impact: Examines healthcare provider behaviors and the impact of health system mergers on adoption strategies.
• Market Updates & Industry Changes: Covers recent regulatory changes, new policies, and emerging technologies.
• Competitive Strategies: Analyzes competitor strategies, market share, and emerging players.
• Pricing & Market Access: Reviews pricing models, reimbursement trends, and market access strategies.
• Market Entry & Expansion: Identifies optimal strategies for entering new markets and partnerships.
• Regional Growth & Investment: Highlights high-growth regions and investment opportunities.
• Supply Chain Optimization: Assesses supply chain risks and distribution strategies for efficient Type delivery.
• Sustainability & Regulatory Impact: Focuses on eco-friendly practices and evolving regulations in healthcare.
• Post-market Surveillance: Uses post-market data to enhance product safety and access.
• Pharmacoeconomics & Value-Based Pricing: Analyzes the shift to value-based pricing and data-driven decision-making in R&D.

The global smart stents market report would provide approximately 45 tables, 46 figures, and 180 pages.

Target Audience 2024

• Manufacturers: Pharmaceutical, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.
• Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.
• Technology & Innovation: R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.
• Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.
• Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.
• Supply Chain: Distribution and Supply Chain Managers.
• Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies.
• Academic & Research: Academic Institutions.

Table of Contents

1. Methodology and Scope

• 1.1. Research Methodology
• 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

• 3.1. Snippet by Type
• 3.2. Snippet by End-User
• 3.3. Snippet by Region

4. Dynamics

• 4.1. Impacting Factors
  • 4.1.1. Drivers
    • 4.1.1.1. Increasing Demand for Minimally Invasive Procedures
    • 4.1.1.2. Rising Incidence of Chronic Diseases
  • 4.1.2. Restraints
    • 4.1.2.1. High Costs of Smart Sensors
    • 4.1.2.2. Regulatory Challenges
  • 4.1.3. Opportunities
    • 4.1.3.1. Rising Technological Advancements
  • 4.1.4. Impact Analysis

5. Strategic Insights and Industry Outlook

• 5.1. Market Leaders and Pioneers
  • 5.1.1. Emerging Pioneers and Prominent Players
  • 5.1.2. Established leaders with largest-selling Brand
  • 5.1.3. Market leaders with established Product
• 5.2. CXO Perspectives
• 5.3. Latest Developments and Breakthroughs
• 5.4. Case Studies/Ongoing Research
• 5.5. Regulatory and Reimbursement Landscape
  • 5.5.1. North America
  • 5.5.2. Europe
  • 5.5.3. Asia Pacific
  • 5.5.4. Latin America
  • 5.5.5. Middle East & Africa
• 5.6. Porter's Five Forces Analysis
• 5.7. Supply Chain Analysis
• 5.8. Patent Analysis
• 5.9. SWOT Analysis
• 5.10. Unmet Needs and Gaps
• 5.11. Recommended Strategies for Market Entry and Expansion
• 5.12. Scenario Analysis: Best-Case, Base-Case, and Worst-Case Forecasts
• 5.13. Pricing Analysis and Price Dynamics
• 5.14. Key Opinion Leaders

6. By Type

• 6.1. Introduction
  • 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
  • 6.1.2. Market Attractiveness Index, By Type
• 6.2. Cardiovascular Smart Stents*
  • 6.2.1. Introduction
  • 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
• 6.3. Urological Smart Stents
• 6.4. Biliary Smart Stents
• 6.5. Respiratory Smart Stents
• 6.6. Others

7. By End-User

• 7.1. Introduction
  • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
  • 7.1.2. Market Attractiveness Index, By End-User
• 7.2. Hospitals*
  • 7.2.1. Introduction
  • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
• 7.3. Ambulatory Surgical Centers (ASCs)
• 7.4. Specialty Clinics

8. By Region

• 8.1. Introduction
  • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
  • 8.1.2. Market Attractiveness Index, By Region
• 8.2. North America
  • 8.2.1. Introduction
  • 8.2.2. Key Region-Specific Dynamics
  • 8.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
  • 8.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
  • 8.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 8.2.5.1. U.S.
    • 8.2.5.2. Canada
• 8.3. Europe
  • 8.3.1. Introduction
  • 8.3.2. Key Region-Specific Dynamics
  • 8.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
  • 8.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
  • 8.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 8.3.5.1. Germany
    • 8.3.5.2. U.K.
    • 8.3.5.3. France
    • 8.3.5.4. Spain
    • 8.3.5.5. Italy
    • 8.3.5.6. Rest of Europe
• 8.4. Latin America
  • 8.4.1. Introduction
  • 8.4.2. Key Region-Specific Dynamics
  • 8.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
  • 8.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
  • 8.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 8.4.5.1. Mexico
    • 8.4.5.2. Brazil
    • 8.4.5.3. Argentina
    • 8.4.5.4. Rest of South America
• 8.5. Asia-Pacific
  • 8.5.1. Introduction
  • 8.5.2. Key Region-Specific Dynamics
  • 8.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
  • 8.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
  • 8.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 8.5.5.1. China
    • 8.5.5.2. India
    • 8.5.5.3. Japan
    • 8.5.5.4. South Korea
    • 8.5.5.5. Rest of Asia-Pacific
• 8.6. Middle East and Africa
  • 8.6.1. Introduction
  • 8.6.2. Key Region-Specific Dynamics
  • 8.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
  • 8.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User

9. Competitive Landscape

• 9.1. Competitive Scenario
• 9.2. Market Positioning/Share Analysis
• 9.3. Mergers and Acquisitions Analysis

10. Company Profiles

Key Market Players

• 10.1. Cordis*
  • 10.1.1. Company Overview
  • 10.1.2. Product Portfolio
    • 10.1.2.1. Product Description
    • 10.1.2.2. Product Key Performance Indicators (KPIs)
    • 10.1.2.3. Historic and Forecasted Product Sales
    • 10.1.2.4. Product Sales Volume
  • 10.1.3. Financial Overview
    • 10.1.3.1. Company Revenue's
    • 10.1.3.2. Geographical Revenue Shares
    • 10.1.3.3. Revenue Forecasts
  • 10.1.4. Key Developments
    • 10.1.4.1. Mergers & Acquisitions
    • 10.1.4.2. Key Product Development Activities
    • 10.1.4.3. Regulatory Approvals etc.
  • 10.1.5. SWOT Analysis
• 10.2. Boston Scientific Corporation
• 10.3. Abbott
• 10.4. Medtronic
• 10.5. Balton
• 10.6. Biotronik

LIST NOT EXHAUSTIVE

11. Appendix

• 11.1. About Us and Services
• 11.2. Contact Us